BlackRock, Inc. 13D and 13G filings for Amgen Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | Amgen Inc. AMGN | BlackRock Inc. BLK | 40,830,830 7.600% | -6,980,526 (-14.60%) | Filing |
| 2024-01-25 1:48 pm Sale | 2023-12-31 | 13G | Amgen Inc. AMGN | BlackRock Inc. BLK | 47,811,356 8.900% | -701,723 (-1.45%) | Filing |
| 2023-02-07 2:10 pm Sale | 2022-12-31 | 13G | Amgen Inc. AMGN | BlackRock Inc. BLK | 48,513,079 9.100% | -1,533,266 (-3.06%) | Filing |
| 2022-01-31 5:59 pm Purchase | 2021-12-31 | 13G | Amgen Inc. AMGN | BlackRock Inc. BLK | 50,046,345 8.900% | 2,240,551 (+4.69%) | Filing |
| 2021-01-28 6:11 pm Purchase | 2020-12-31 | 13G | Amgen Inc. AMGN | BlackRock Inc. BLK | 47,805,794 8.200% | 1,549,297 (+3.35%) | Filing |